137 related articles for article (PubMed ID: 1665829)
1. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.
Lamberg-Allardt C; Valtonen E; Polojärvi M; Stewen P
Mol Cell Endocrinol; 1991 Oct; 81(1-3):25-31. PubMed ID: 1665829
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxyvitamin D3 attenuates TSH and 8-(4-chlorophenylthio)-cAMP-stimulated growth and iodide uptake by rat thyroid cells (FRTL-5).
Berg JP; Torjesen PA; Haug E
Thyroid; 1993; 3(3):245-51. PubMed ID: 8257867
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxycholecalciferol attenuates thyrotropin stimulated iodide accumulation in rat thyroid follicular FRTL-5 cells by reducing iodide porter number.
Lamberg-Allardt C; Valtonen E
Biochem Biophys Res Commun; 1992 Feb; 182(3):1435-9. PubMed ID: 1311573
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.
Berg JP; Sandvik JA; Ree AH; Sørnes G; Bjøro T; Torjesen PA; Gordeladze JO; Haug E
Endocrinology; 1994 Aug; 135(2):595-602. PubMed ID: 8033808
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 1,25-dihydroxyvitamin D3 receptors and in vivo targeting of [3H]-1,25(OH)2D3 in the sheep placenta.
Ross R; Florer J; Halbert K; McIntyre L
Placenta; 1989; 10(6):553-67. PubMed ID: 2558376
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of 1,25 dihydroxyvitamin D3 in lymphocytes.
Walter RM; Freake HC; Iwasaki J; Lynn J; MacIntyre I
Metabolism; 1984 Mar; 33(3):240-3. PubMed ID: 6319957
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells.
Berg JP; Liane KM; Bjørhovde SB; Bjøro T; Torjesen PA; Haug E
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):145-50. PubMed ID: 8049143
[TBL] [Abstract][Full Text] [Related]
8. Demonstration and characterization of a 1 alpha,25-(OH)2D3 receptor-like macromolecule in cultured rat pituitary cells.
Haug E; Gautvik KM
J Steroid Biochem; 1985 Nov; 23(5A):625-35. PubMed ID: 3001410
[TBL] [Abstract][Full Text] [Related]
9. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
Griffin JE; Zerwekh JE
J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
Atley LM; Lefroy N; Wark JD
J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone.
Gross M; Kost SB; Ennis B; Stumpf W; Kumar R
J Bone Miner Res; 1986 Oct; 1(5):457-67. PubMed ID: 2845731
[TBL] [Abstract][Full Text] [Related]
12. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells.
Petkovich PM; Heersche JN; Tinker DO; Jones G
J Biol Chem; 1984 Jul; 259(13):8274-80. PubMed ID: 6330107
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
[TBL] [Abstract][Full Text] [Related]
15. Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice.
Merke J; Schwittay D; Fürstenberger G; Gross M; Marks F; Ritz E
Calcif Tissue Int; 1985 May; 37(3):257-67. PubMed ID: 2990643
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro.
Koh E; Morimoto S; Fukuo K; Itoh K; Hironaka T; Shiraishi T; Onishi T; Kumahara Y
Life Sci; 1988; 42(2):215-23. PubMed ID: 2826956
[TBL] [Abstract][Full Text] [Related]
17. Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype.
Gacad MA; Adams JS
Endocrinology; 1992 Dec; 131(6):2581-7. PubMed ID: 1446602
[TBL] [Abstract][Full Text] [Related]
18. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
[TBL] [Abstract][Full Text] [Related]
19. The ovary: a target organ for 1,25-dihydroxyvitamin D3.
Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR
Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty.
Walters MR
Endocrinology; 1984 Jun; 114(6):2167-74. PubMed ID: 6327237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
